Fameglow Holdings Limited (HKG:8603)

Verve Therapeutics Cash Flow Statement

Financials in millions HKD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	45.73	40.75	16.37	-8.78	-26.96
Depreciation & Amortization	59.7	46.23	46.81	43.18	29.69
Loss (Gain) From Sale of Assets	-	-0.86	-	-	-
Asset Writedown & Restructuring Costs	-	-	4.36	-	-
Other Operating Activities	0.97	1.37	2.18	5.6	1.22
Change in Accounts Receivable	-64	-18.36	4.7	-6.78	-3.04
Change in Inventory	-1.4	-2.38	4.94	-4.16	-2.35
Change in Accounts Payable	45.19	2.51	10.06	2.33	0.68
Change in Unearned Revenue	-4.04	-37.16	-10.91	-4.03	18.89
Change in Other Net Operating Assets	1.39	2.7	-4.44	-2.62	0.15
Operating Cash Flow	83.53	34.8	74.07	24.74	18.27
Operating Cash Flow Growth	140.03%	-53.02%	199.44%	35.36%	16.49%
Capital Expenditures	-53.39	-13.46	-32.2	-34.45	-11.45
Divestitures	-	1.95	-	-	-
Other Investing Activities	18.08	4.6	0.01	-	7.55
Investing Cash Flow	-35.31	-6.91	-32.18	-34.45	-3.9
Short-Term Debt Issued	8.5	-	6	2	19.67
Total Debt Issued	8.5	-	6	2	19.67
Short-Term Debt Repaid	-5.56	-4.36	-5.91	-5.35	-16.44
Long-Term Debt Repaid	-25.93	-20.35	-20.64	-19.77	-14.27
Total Debt Repaid	-31.49	-24.71	-26.55	-25.12	-30.71
Net Debt Issued (Repaid)	-22.99	-24.71	-20.55	-23.12	-11.04
Other Financing Activities	-3.93	-3.08	-3.76	-4.91	-3.17
Financing Cash Flow	-26.92	-27.8	-24.31	-28.03	-14.21
Net Cash Flow	21.31	0.09	17.58	-37.74	0.16
Free Cash Flow	30.14	21.34	41.87	-9.71	6.82
Free Cash Flow Growth	41.27%	-49.05%	-	-	-
Free Cash Flow Margin	6.93%	7.13%	18.40%	-5.41%	8.31%
Free Cash Flow Per Share	0.04	0.03	0.05	-0.01	0.01
Cash Interest Paid	3.93	3.08	3.76	4.91	3.17
Cash Income Tax Paid	10.32	4.93	0.18	0.04	0.8
Levered Free Cash Flow	61.83	4.57	20.81	-6.63	16.47
Unlevered Free Cash Flow	64.38	6.54	23.18	-3.53	18.45
Change in Working Capital	-22.87	-52.69	4.35	-15.26	14.32

Source: S&P Global Market Intelligence. Standard template. Financial Sources.